See also previous blogs (the index is working again thanks to the best IT team in the world!). Twice we recommended buying this stock, each time it dropped a bit the days immediately afterward so if you had acted on that you should own the stock on average at around $7.60 or so. For reasons described in those blogs this stock should go up. It is now at $10.23, up 34%. Presently $11.17 (up 47%) is within reasonable possibilities as that represents the 4th wave of wave 5 of 5, more or less a minimum expectation. Ultimately it may go a lot further but we would recommend using a stop when going into the buy-and-hold mode,
STJ, St. Jude Medical update
The then (July 6th, 2012 and earlier) and now charts;
At the time there were two distinct possibilities, the purple one where the stock would go down immediately or the green one where much of wave c of wave 2 still had to develop. QEs and other simulative measures no doubt contributed to the more time consuming second option. Today we got down to almost $30 ($12 below the level in June). This looks like a third wave that may have quite a bit more to go. Apparently an FDA report was released revealing that certain cables could easily fray and jeopardize the proper functioning of a heart device. Sounds innocent enough. Going lower!
JNJ update
See also previous blogs;
As expected JNJ has started to break down. Two counts are possible, one with a triangle in the middle and the other with a straightforward (running) flat. Both roads lead to Rome and it is purely academic which is the correct one. If one uses one’s imagination a 5th wave could even be argued with identical consequences. The double top is icing on the cake. A sell.